date,title,source
Oct-25-18,MeiraGTx Expands Leadership Team with Appointment of Katherine Breedis as Chief Financial Officer,GlobeNewswire
Nov-08-18,MeiraGTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Nov-08-18,MeiraGTx Reports Third Quarter 2018 Financial Results and Provides Corporate Update,GlobeNewswire
Dec-12-18,MeiraGTx Announces Publication of New Research Identifying Underlying Mechanism of Functional Improvement Seen with AAV-GAD Gene Therapy in Parkinsons Disease,GlobeNewswire
Jan-02-19,MeiraGTx to Present at the 37th Annual J.P. Morgan Healthcare Conference,GlobeNewswire
Jan-04-19,Do Directors Own MeiraGTx Holdings plc (NASDAQ:MGTX) Shares?,Simply Wall St.
Jan-31-19,MeiraGTx Enters into Strategic Collaboration with Janssen to Develop and Commercialize Gene Therapy Treatments for Inherited Retinal Diseases,GlobeNewswire
Jan-31-19,Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases,PR Newswire
Feb-05-19,MeiraGTx to Present at the BIO CEO & Investor Conference,GlobeNewswire
Feb-21-19,"MeiraGTx Appoints Martin Indyk, Ph.D. to Board of Directors",GlobeNewswire
Feb-27-19,MeiraGTx Announces $80 Million Private Placement of Ordinary Shares,GlobeNewswire
Mar-04-19,Why NOW Is the Time to Buy Gene Therapy Stocks,InvestorPlace
Mar-06-19,MeiraGTx to Present at the Barclays Global Healthcare Conference,GlobeNewswire
Mar-11-19,Johnson & Johnson Buys Large Stake in MeiraGTx,Barrons.com
Mar-26-19,MeiraGTx Reports Full Year 2018 Financial Results,GlobeNewswire
Apr-24-19,5 Biotech Stocks Defying the Medicare-for-All Scare,Zacks
Apr-25-19,MeiraGTx Announces Upcoming Presentation on Achromatopsia Gene Therapy Candidate AAV-CNGA3 at ARVO 2019,GlobeNewswire
Apr-25-19,"The Zacks Analyst Blog Highlights: Incyte, Aduro Biotech, MeiraGTx and Coherus BioSciences",Zacks
May-06-19,MeiraGTx to Present at Bank of America Merrill Lynch Healthcare Conference,GlobeNewswire
May-10-19,MeiraGTx Appoints Nicole Seligman to Board of Directors,GlobeNewswire
May-14-19,MeiraGTx Reports First Quarter 2019 Financial Results and Provides Corporate Update,GlobeNewswire
May-14-19,MeiraGTx Announces Positive 6-Month Data from Phase 1/2 Trial of Investigational Gene Therapy AAV-RPE65 for RPE65-Deficiency,GlobeNewswire
May-17-19,Why This Biotech Stock Looks Prime For A Johnson & Johnson Buyout,Investor's Business Daily
